EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients

Manuela Rizzi iD, Stelvio Tonello iD, Davide D'Onghia iD, Pier Paolo Sainaghi iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24020951 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Manuela Rizzi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy. Hauptthemen laut MEDLINE: Pandemics, COVID-19. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gas6 (growth arrest-specific gene 6) is a widely expressed vitamin K-dependent protein that is involved in many biological processes such as homeostatic regulation, inflammation and repair/fibrotic processes. It is known that it is the main ligand of TAMs, a tyrosine kinase receptor family of three members, namely MerTK, Tyro-3 and Axl, for which it displays the highest affinity. Gas6/TAM axis activation is known to be involved in modulating inflammatory responses as well as fibrotic evolution in many different pathological conditions. Due to the rapidly evolving COVID-19 pandemic, this review will focus on Gas6/TAM axis activation in SARS-CoV-2 infection, where de-regulated inflammatory responses and fibrosis represent a relevant feature of severe disease manifestation. Furthermore, this review will highlight the most recent scientific evidence supporting an unsuspected role of Axl as a SARS-CoV-2 infection driver, and the potential therapeutic advantages of the use of existing Axl inhibitors in COVID-19 management. From a physiological point of view, the Gas6/TAM axis plays a dual role, fostering the tissue repair processes or leading to organ damage and loss of function, depending on the prevalence of its anti-inflammatory or profibrotic properties. This review makes a strong case for further research focusing on the Gas6/TAM axis as a pharmacological target to manage different disease conditions, such as chronic fibrosis or COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PandemicsCOVID-19Inflammationc-Mer Tyrosine KinaseHumansDown SyndromeLeukemoid ReactionFibrosisSARS-CoV-2

Stichwörter der Autor:innen

COVID-19Gas6TAM receptorsfibrosisinflammation

Substanzen

c-Mer Tyrosine Kinase

Autor:innen und Institutionen

  • Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy.

ORCID-Profile: Manuela Rizzi, Stelvio Tonello, Davide D'Onghia, Pier Paolo Sainaghi

Zitieren

APA

Rizzi, M., Tonello, S., D'Onghia, D., & Sainaghi, P. P. (2023). Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24020951

Vancouver

Rizzi M, Tonello S, D'Onghia D, Sainaghi PP. Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24020951

BibTeX
@article{Rizzi2023,
  author = {Rizzi, Manuela and Tonello, Stelvio and D'Onghia, Davide and Sainaghi, Pier Paolo},
  title = {Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24020951}
}
Kostenlos starten →